These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 23493729)

  • 1. A peptide antagonist of CD28 signaling attenuates toxic shock and necrotizing soft-tissue infection induced by Streptococcus pyogenes.
    Ramachandran G; Tulapurkar ME; Harris KM; Arad G; Shirvan A; Shemesh R; Detolla LJ; Benazzi C; Opal SM; Kaempfer R; Cross AS
    J Infect Dis; 2013 Jun; 207(12):1869-77. PubMed ID: 23493729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of superantigen toxins into the CD28 homodimer interface is essential for induction of cytokine genes that mediate lethal shock.
    Arad G; Levy R; Nasie I; Hillman D; Rotfogel Z; Barash U; Supper E; Shpilka T; Minis A; Kaempfer R
    PLoS Biol; 2011 Sep; 9(9):e1001149. PubMed ID: 21931534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Staphylococcal and Streptococcal Superantigens Trigger B7/CD28 Costimulatory Receptor Engagement to Hyperinduce Inflammatory Cytokines.
    Popugailo A; Rotfogel Z; Supper E; Hillman D; Kaempfer R
    Front Immunol; 2019; 10():942. PubMed ID: 31114583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lethal shock induced by streptococcal pyrogenic exotoxin A in mice transgenic for human leukocyte antigen-DQ8 and human CD4 receptors: implications for development of vaccines and therapeutics.
    Welcher BC; Carra JH; DaSilva L; Hanson J; David CS; Aman MJ; Bavari S
    J Infect Dis; 2002 Aug; 186(4):501-10. PubMed ID: 12195377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacterial superantigens promote acute nasopharyngeal infection by Streptococcus pyogenes in a human MHC Class II-dependent manner.
    Kasper KJ; Zeppa JJ; Wakabayashi AT; Xu SX; Mazzuca DM; Welch I; Baroja ML; Kotb M; Cairns E; Cleary PP; Haeryfar SM; McCormick JK
    PLoS Pathog; 2014 May; 10(5):e1004155. PubMed ID: 24875883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Superantigen antagonist protects against lethal shock and defines a new domain for T-cell activation.
    Arad G; Levy R; Hillman D; Kaempfer R
    Nat Med; 2000 Apr; 6(4):414-21. PubMed ID: 10742148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies to the conserved region of the M protein and a streptococcal superantigen cooperatively resolve toxic shock-like syndrome in HLA-humanized mice.
    Pandey M; Calcutt A; Ozberk V; Chen Z; Croxen M; Powell J; Langshaw E; Mills JL; Jen FE; McCluskey J; Robson J; Tyrrell GJ; Good MF
    Sci Adv; 2019 Sep; 5(9):eaax3013. PubMed ID: 31517054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Necrotizing soft tissue infections caused by Streptococcus pyogenes and Streptococcus dysgalactiae subsp. equisimilis of groups C and G in western Norway.
    Bruun T; Kittang BR; de Hoog BJ; Aardal S; Flaatten HK; Langeland N; Mylvaganam H; Vindenes HA; Skrede S
    Clin Microbiol Infect; 2013 Dec; 19(12):E545-50. PubMed ID: 23795951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Streptococcus pyogenes: Insight into the function of the streptococcal superantigens.
    Sriskandan S; Faulkner L; Hopkins P
    Int J Biochem Cell Biol; 2007; 39(1):12-9. PubMed ID: 17029999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Superantigen antagonist blocks Th1 cytokine gene induction and lethal shock.
    Arad G; Hillman D; Levy R; Kaempfer R
    J Leukoc Biol; 2001 Jun; 69(6):921-7. PubMed ID: 11404377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD28: direct and critical receptor for superantigen toxins.
    Kaempfer R; Arad G; Levy R; Hillman D; Nasie I; Rotfogel Z
    Toxins (Basel); 2013 Sep; 5(9):1531-42. PubMed ID: 24022021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The bacterial superantigen streptococcal mitogenic exotoxin Z is the major immunoactive agent of Streptococcus pyogenes.
    Unnikrishnan M; Altmann DM; Proft T; Wahid F; Cohen J; Fraser JD; Sriskandan S
    J Immunol; 2002 Sep; 169(5):2561-9. PubMed ID: 12193726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Superantigen antagonist peptides.
    Llewelyn M; Cohen J
    Crit Care; 2001; 5(2):53-5. PubMed ID: 11299061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Broad-spectrum immunity against superantigens is elicited in mice protected from lethal shock by a superantigen antagonist peptide.
    Arad G; Hillman D; Levy R; Kaempfer R
    Immunol Lett; 2004 Feb; 91(2-3):141-5. PubMed ID: 15019282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Streptococcal superantigen-induced expansion of human tonsil T cells leads to altered T follicular helper cell phenotype, B cell death and reduced immunoglobulin release.
    Davies FJ; Olme C; Lynskey NN; Turner CE; Sriskandan S
    Clin Exp Immunol; 2019 Jul; 197(1):83-94. PubMed ID: 30815853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The contribution of group A streptococcal virulence determinants to the pathogenesis of sepsis.
    Reglinski M; Sriskandan S
    Virulence; 2014 Jan; 5(1):127-36. PubMed ID: 24157731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The bacterial superantigen and superantigen-like proteins.
    Fraser JD; Proft T
    Immunol Rev; 2008 Oct; 225():226-43. PubMed ID: 18837785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Superantigens and streptococcal toxic shock syndrome.
    Proft T; Sriskandan S; Yang L; Fraser JD
    Emerg Infect Dis; 2003 Oct; 9(10):1211-8. PubMed ID: 14609454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defense against biologic warfare with superantigen toxins.
    Kaempfer R; Arad G; Levy R; Hillman D
    Isr Med Assoc J; 2002 Jul; 4(7):520-3. PubMed ID: 12120463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MAIT cells launch a rapid, robust and distinct hyperinflammatory response to bacterial superantigens and quickly acquire an anergic phenotype that impedes their cognate antimicrobial function: Defining a novel mechanism of superantigen-induced immunopathology and immunosuppression.
    Shaler CR; Choi J; Rudak PT; Memarnejadian A; Szabo PA; Tun-Abraham ME; Rossjohn J; Corbett AJ; McCluskey J; McCormick JK; Lantz O; Hernandez-Alejandro R; Haeryfar SMM
    PLoS Biol; 2017 Jun; 15(6):e2001930. PubMed ID: 28632753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.